Coologics aims to revolutionize women's health by providing innovative, drug-free solutions for vaginal infections. The company is committed to developing sustainable treatments that reduce the unnecessary use of antibiotics, addressing the growing concern of antibiotic resistance. Vlisse is an innovative, drug-free intravaginal cooling device designed to treat vaginal infections, including VVC, BV, and mixed infections by leveraging its patented cooling mechanism. This approach represents a paradigm shift from traditional antifungal drugs, focusing on restoring the vaginal environment to a healthy state without the use of chemicals.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/24/25 | $3,000,000 | Seed |
Dream Ventures Illinois Ventures Ohio State Early Investor Network Prevail  | undisclosed |
